# Hospital Stocks Rally After Cancer Drug Price Caps

> Hospital stocks jump up to 5% as India caps cancer drug margins at 30%.
- Title: Hospital Stocks Rally After Cancer Drug Price Caps | Shortify
- Summary: Hospital stocks jump up to 5% as India caps cancer drug margins at 30%. India's hospital stocks rose 4-5% after government capped cancer drug trade margins…
- Keywords: apollo hospitals, max health, hospital stocks, cancer drug price cap, jefferies, fortis healthcare, medanta, manipal, cancer treatment, drug margins, price caps, hospital stocks rally
- Source: The Economic Times — https://economictimes.indiatimes.com/markets/stocks/news/apollo-hospitals-max-health-hospital-stocks-jump-up-to-5-after-30-cap-on-cancer-drugs-what-is-jefferies-saying/articleshow/134811131.cms
- Author: Veer Sharma
- Published: 2026-10-09T05:44:00+00:00
- Read time: 1 min
- Topics: apollo hospitals, max health, hospital stocks, cancer drug price cap, jefferies, fortis healthcare, medanta, manipal, cancer treatment, drug margins, price caps, hospital stocks rally
## Hospital Stocks Rally
Hospital stocks including Fortis Healthcare, Dr Agarwal’s, Manipal, Apollo Hospitals and Medanta gained up to 5% on Friday after the government decided to cap trade margins on non-scheduled anti-cancer drugs at 30%.
## Price Cap Impact
The move could reduce cancer medicine prices by up to 70% and save patients an estimated Rs 2,500 crore annually.
## Jefferies Stance
Jefferies says near-term margins could be impacted but recommends Buy as regulatory uncertainty eases for now.
## Consumables Impact
Jefferies estimates consumables account for 12-15% of a patient's hospital bill but margins in this segment are relatively low.
## Historical Context
Hospitals offset margin impacts through staggered procedure charges and cost rationalisation over 12-15 months.
## Past Recovery
Apollo Hospitals restored EBITDA margins to previous levels within a few quarters after price caps on stents and implants in 2017.
## Current Valuation
Hospital stocks trade at 21x-25x FY28E EV/EBITDA compared with 25x-35x a year ago.
## Jefferies Picks
Jefferies recommends Fortis, Manipal, Apollo Hospitals, Max Healthcare and Medanta as preferred picks for sustainable EBITDA growth.
## Patient Coverage
Margin caps likely affect cash-paying patients while insurance and public health schemes use pre-negotiated package rates.
## Key takeaway

India's hospital stocks rose 4-5% after government capped cancer drug trade margins at 30%, potentially saving patients Rs 2,500 crore annually.